imiquimod has been researched along with Eczema in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 6 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, D; Li, F; Lu, S; Meng, L; Mou, K; Wang, B; Xu, J; Zhang, W; Zhao, Y; Zhou, Y; Zhu, W | 1 |
| Chung, JH; Jo, SJ; Kim, EJ; Kim, SJ; Kim, TG; Lee, Y; Ohn, J; Suh, JH | 1 |
| Chen, H; Ge, W; Huang, Y; Jiang, J; Jin, Z; Kong, Y; Li, F; Li, L; Li, M; Liu, X; Zeng, X; Zhanmu, O | 1 |
| Abram, CL; Bevilacqua, D; Cassatella, MA; Caveggion, E; Cestari, T; Constantin, G; Costa, S; De Sanctis, F; Donini, M; Dusi, S; Gasperini, S; Girolomoni, G; Lonardi, S; Lowell, CA; Pettinella, F; Rodegher, P; Scapini, P; Tagliaro, F; Ugel, S; Vermi, W; Zenaro, E | 1 |
| Bang, J; Bareja, R; Desman, G; Ding, W; Elemento, O; Eljalby, M; Granstein, RD; Miller, LS; Reilly, MD; Vyas, NS; You, J; Yusupova, M; Zippin, JH | 1 |
| Jiang, Y; Lai, Y; Lu, S; Wang, L | 1 |
| Chu, J; Hartman, R; Meehan, S; Patel, R; Stein, JA | 1 |
| Kapembwa, M; Maslen, M; Taylor, CL | 1 |
1 review(s) available for imiquimod and Eczema
| Article | Year |
|---|---|
Extramammary Paget disease.
Topics: Aminoquinolines; Antineoplastic Agents; Asian People; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Diagnostic Errors; Eczema; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Penile Neoplasms; Scrotum; Skin Neoplasms | 2011 |
7 other study(ies) available for imiquimod and Eczema
| Article | Year |
|---|---|
Topical Treatment of Colquhounia Root Relieves Skin Inflammation and Itch in Imiquimod-Induced Psoriasiform Dermatitis in Mice.
Topics: Animals; Disease Models, Animal; Eczema; Imiquimod; Inflammation; Mice; Psoriasis; Skin | 2022 |
Adiponectin-derived pentapeptide ameliorates psoriasiform skin inflammation by suppressing IL-17 production in γδT cells.
Topics: Adiponectin; Animals; Disease Models, Animal; Eczema; Imiquimod; Inflammation; Interleukin-17; Mice; Psoriasis; Receptors, Adiponectin; Skin | 2022 |
Role of Type I Cannabinoid Receptor in Sensory Neurons in Psoriasiform Skin Inflammation and Pruritus.
Topics: Animals; Eczema; Imiquimod; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Pruritus; Psoriasis; Receptors, Cannabinoid; Sensory Receptor Cells; Substance P | 2023 |
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis.
Topics: Animals; Disease Models, Animal; Disease Progression; Eczema; Imiquimod; Mice; NADP; NADPH Oxidases; Neutrophils; Psoriasis | 2022 |
Soluble adenylyl cyclase contributes to imiquimod-mediated inflammation and is a potential therapeutic target in psoriasis.
Topics: Adenylyl Cyclases; Animals; Disease Models, Animal; Eczema; Imiquimod; Inflammation; Mice; Psoriasis; Skin; Th17 Cells | 2023 |
Topical histone deacetylase 1 inhibitor Entinostat ameliorates psoriasiform dermatitis through suppression of IL-17A response.
Topics: Animals; Disease Models, Animal; Eczema; Histone Deacetylase 1; Humans; Imiquimod; Interleukin-17; Mice; Mice, Inbred BALB C; Psoriasis; Skin | 2023 |
A case of severe eczema following use of imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Condylomata Acuminata; Drug Eruptions; Eczema; Humans; Imiquimod; Male; Ointments; Penile Diseases | 2006 |